» Articles » PMID: 29477084

Differences in Time to Injection Onset by Drug in California: Implications for the Emerging Heroin Epidemic

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2018 Feb 25
PMID 29477084
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Heroin use is increasing in the US. Heroin use may predispose users towards injection routes of drug administration as compared to other illicit substances.

Objective: To explore the relationship between heroin use and drug injection, we compared time from first use to first injection (referred to as time to injection onset by drug [TTIOD]) of heroin, methamphetamine/speed, cocaine, and crack cocaine among people who inject drugs (PWID).

Methods: Age of first use and first injection by drug was collected from 776 PWID. Survival analyses were used to determine TTIOD and to examine demographic factors associated with TTIOD. Cox regression analysis was used to determine demographic factors associated with drug-specific injection onset.

Results: The eventual injection onset rate by the drug was 99% for participants who used heroin, 85% for participants who used methamphetamine/speed, 80% for participants who used powder cocaine, and 38% for participants who used crack cocaine. Hazard ratios for injection use within one year of first use by drug were: 1.37 (median survival time [MST] = 0.61 years) for heroin, 0.66 (MST = 1.10 years) for methamphetamine/speed, 0.50 (MST = 2.93 years) for powder cocaine, and 0.12 (MST = 39.59 years) for crack cocaine. Demographic differences in TTIOD were found for each drug. Demographic differences were found for eventual injection by drug for all substances except heroin.

Conclusion: Among PWID, heroin use was associated with a more rapid transition to injection and a higher rate of eventual heroin injection regardless of demographics. More robust, innovative efforts to reduce heroin use and prevent injection initiation are urgently needed.

Citing Articles

PrEP for people who use opioids: A NIDA clinical trials network survey study in Southern U.S. cities where HIV incidence is high.

Hatch M, Laschober T, Paschen-Wolff M, Ertl M, Nelson C, Wright L Drug Alcohol Depend. 2024; 257:111133.

PMID: 38447393 PMC: 11131129. DOI: 10.1016/j.drugalcdep.2024.111133.


The influence of transformations in supply on methamphetamine initiation among people injecting opioids in the United States.

Mars S, Ondocsin J, Holm N, Ciccarone D Harm Reduct J. 2024; 21(1):57.

PMID: 38443903 PMC: 10913463. DOI: 10.1186/s12954-024-00976-1.


Early OxyContin Marketing Linked To Long-Term Spread Of Infectious Diseases Associated With Injection Drug Use.

Dennett J, Gonsalves G Health Aff (Millwood). 2023; 42(8):1081-1090.

PMID: 37467441 PMC: 10521060. DOI: 10.1377/hlthaff.2023.00146.


A Pilot Study of Polysubstance Use Sequences across the Lifespan among Assiniboine and Sioux People Who Use Injection Drugs.

Anastario M, Firemoon P, Rodriguez A, Wade C, Prokosch C, Rink E Int J Environ Res Public Health. 2023; 20(1).

PMID: 36612865 PMC: 9819103. DOI: 10.3390/ijerph20010543.


The Changing Epidemiology of Hepatitis C Virus Infection in the United States During the Years 2010 to 2018.

Holtzman D, Asher A, Schillie S Am J Public Health. 2021; 111(5):949-955.

PMID: 33734844 PMC: 8034015. DOI: 10.2105/AJPH.2020.306149.


References
1.
. Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009. MMWR Morb Mortal Wkly Rep. 2011; 60(17):537-41. View

2.
Kolla G, Strike C, Roy E, Altenberg J, Balian R, Silver R . Initiation Stories: An Examination of the Narratives of People Who Assist With a First Injection. Subst Use Misuse. 2015; 50(13):1619-27. DOI: 10.3109/10826084.2015.1023456. View

3.
McBride A, Pates R, Arnold K, Ball N . Needle fixation, the drug user's perspective: a qualitative study. Addiction. 2001; 96(7):1049-58. DOI: 10.1046/j.1360-0443.2001.967104914.x. View

4.
Manchikanti L, Helm 2nd S, Fellows B, Janata J, Pampati V, Grider J . Opioid epidemic in the United States. Pain Physician. 2012; 15(3 Suppl):ES9-38. View

5.
Wenger L, Lopez A, Kral A, Bluthenthal R . Moral ambivalence and the decision to initiate others into injection drug use: A qualitative study in two California cities. Int J Drug Policy. 2016; 37:42-51. DOI: 10.1016/j.drugpo.2016.07.008. View